| [1] |
Targher G. Non-alcoholic fatty liver disease as driving force in coronary heart disease Gut, 2017, 66:213-214.
|
| [2] |
Ghouri N, Preiss D, Sattar N. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology, 2010, 52: 1156-1161.
|
| [3] |
Targher G, Byrne CD, Lonardo A, et al. Nonalcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol,2016, 65: 589-600.
|
| [4] |
Sinn D H, Kang D, Chang Y, et al. Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study. Gut, 2017, 661: 323-329.
|
| [5] |
Bhatia L, Scorletti E, Curzen N, et al. Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression. Atherosclerosis, 2016, 246: 13-20.
|
| [6] |
Pais R, Giral P, Khan J F, et al. Fatty liver is an independent predictor of early carotid atherosclerosis. J Hepatol, 2016, 651: 95-102.
|
